ライフサイエンスコーパス: cause of disease

1 ction of sophisticated exotoxins is the main cause of disease.

2 limination of classical biotype strains as a cause of disease.

3 h as multiple sclerosis may be a clue to the cause of disease.

4 21ins2) is the predominant but not exclusive cause of disease.

5 h as multiple sclerosis may be a clue to the cause of disease.

6 iral immune response within the brain is the cause of disease.

7 occus, serotype V (GBS-V), was an infrequent cause of disease.

8 gation is increasingly being recognized as a cause of disease.

9 T) were helpful in suggesting the underlying cause of disease.

10 Smoking is a common addiction and a leading cause of disease.

11 Mycobacterium mucogenicum was the leading cause of disease.

12 (tubulin beta-4; Arg2Gly) gene as the likely cause of disease.

13 mutations in sarcomere protein genes as the cause of disease.

14 tation-induced loss of stability is a common cause of disease.

15 ed to the establishment of autoimmunity as a cause of disease.

16 r, a prime candidate gene, was excluded as a cause of disease.

17 laboratory evaluations to exclude secondary causes of disease.

18 action between the genetic and environmental causes of disease.

19 smaller subfibrillar oligomers are the prime causes of disease.

20 igins, susceptibility to illness and genetic causes of disease.

21 aware of inherited genetic abnormalities as causes of disease.

22 nt susceptibility to two vaccine-preventable causes of disease.

23 cerned with determining the distribution and causes of disease.

24 worry, and depression are significant direct causes of disease.

25 sed to predict new functions in proteins and causes of disease.

26 studies are important tools for identifying causes of disease.

27 ulation of Notch signaling is the underlying cause of diseases affecting the skeletal tissue, includi

28 Falciparum malaria is a major cause of disease and death in African children and pregn

29 uman cytomegalovirus (HCMV) is a significant cause of disease and death in immunocompromised patients

30 s a ubiquitous herpesvirus and a significant cause of disease and death in the immunocompromised and

31 PIV is an established cause of disease and death in the pediatric and immunoco

32 inues to question whether tobacco is a major cause of disease and death.

33 Smoking is a leading global cause of disease and mortality.

34 f mitochondrial DNA (mtDNA) are an important cause of disease and play a role in the ageing process.

35 Nematodes are a major cause of disease and the discovery of new pathways not f

36 y demonstrated that ANCAs are a transferable cause of disease and this is supported by studies of the

37 will permit us to investigate the underlying cause of diseases and help us to develop therapeutics.

38 rting to take into account the polymicrobial cause of diseases and the repercussions of treatment and

39 Obesity is among the leading causes of disease and death.

40 nts about health losses associated with many causes of disease and injury were elicited from the gene

41 this genome are now recognized as important causes of disease and may take the form of point mutatio

42 Neglected diseases remain one of the largest causes of disease and mortality.

43 at facilitates elucidation of the underlying causes of disease and the best ways to target them.

44 g whole chromosomes, have been identified as causes of diseases and developmental abnormalities and a

45 rigorous and unbiased conclusions about the causes of diseases and their population-wide impact will

46 ate diagnosis, recognition of the modifiable causes of disease, assessment of symptoms and complicati

47 or injecting drug use (IDU) is a substantial cause of disease burden and a contributor to blood-borne

48 pwards of two billion people and are a major cause of disease burden in children and pregnant women.

49 arette smoking remains the leading avoidable cause of disease burden worldwide, and observational stu

50 Major depressive disorder (MDD) is a leading cause of disease burden worldwide.

51 Depression is a leading cause of disease burden, yet current therapies fully tre

52 and other developing regions is an important cause of disease burden.

53 heterogeneity exists in rankings of leading causes of disease burden among regions.

54 ilable resources effectively to reduce major causes of disease burden globally and to decrease health

55 od pressure, and high cholesterol were major causes of disease burden.

56 nd nutritional disorders remain the dominant causes of disease burden.

57 ead in mammalian genomes and is an important cause of disease, but just how abundant and important st

58 chanisms integrate genetic and environmental causes of disease, but comprehensive genome-wide analyse

59 e proven to be helpful for finding genotypic causes of diseases, classifying disease subtypes, and id

60 ined the human genome (G) mainly to discover causes of disease, despite evidence that G explains rela

61 dysfunction, arguing for a tissue autonomous cause of disease development.

62 ention of mutant transcripts, are probably a cause of disease development.

63 bacco use remains the number-one preventable cause of disease, disability, and death in the United St

64 Smoking is the leading preventable cause of disease, disability, and premature death.

65 (immune-mediated pathology) is a ubiquitous cause of disease during infection, but how will parasite

66 kely that B. miyamotoi is an underrecognized cause of disease, especially in sites where Lyme disease

67 types that were disproportionately common as causes of disease, even taking into account their relati

68 ed loss of lung function compared with other causes of disease exacerbation.

69 It is important to identify the cause of disease for a better disease prognosis and a po

70 sing mutations and may represent a molecular cause of disease for a number of inherited and somatic m

71 has been progress in defining the underlying cause of disease for some patients of muscular dystrophy

72 The immune system can be a cure or cause of disease, fulfilling a protective role in attack

73 whether distinct genes represent independent causes of disease (heterogeneity) or whether they intera

74 mising tool for investigating the underlying causes of disease; however, this potential currently rem

75 We sought to identify the cause of disease in 3 unrelated Finnish kindreds with va

76 an important neonatal pathogen and emerging cause of disease in adults.

77 ale germ cell-associated kinase (MAK) as the cause of disease in an isolated individual with RP.

78 la catarrhalis continues to be a significant cause of disease in both children and adults, the steps

79 m, trypanosomes, and Leishmania, are a major cause of disease in both humans and other animals, highl

80 Serogroup C was the main cause of disease in Brazil; the majority of disease seen

81 Diarrheal disease is the second leading cause of disease in children less than 5 y of age.

82 s, they are now increasingly recognized as a cause of disease in dogs in temperate climates and urban

83 infections in children as well as a serious cause of disease in elderly and immunosuppressed populat

84 netic and genomic approaches to identify the cause of disease in extensive pedigrees comprising over

85 ogen Pneumocystis jirovecii is a significant cause of disease in HIV-infected patients and others wit

86 Pseudomonas aeruginosa is an important cause of disease in hospitalized and immunocompromised p

87 overburden the immune system and are a major cause of disease in humans.

88 s a commensal organism in poultry and as the cause of disease in humans.

89 Candida albicans is a significant cause of disease in immunocompromised humans.

90 s organism has recently been recognized as a cause of disease in immunocompromised patients, presenti

91 is to efficiently determine the presence and cause of disease in order to provide the most appropriat

92 strated that mutations in this gene were the cause of disease in other, unrelated families.

93 X-770) was designed to target the underlying cause of disease in patients with cystic fibrosis.

94 To identify the cause of disease in patients without JAG1 mutations, we

95 ions due to Cryptococcus neoformans, a major cause of disease in persons with AIDS and other disorder

96 lude Mycobacterium tuberculosis complex as a cause of disease in smear-positive respiratory specimens

97 e biogenesis defect and thus constitutes the cause of disease in the affected individuals.

98 genes were performed to identify the genetic cause of disease in the family with the Carney complex a

99 To determine the cause of disease in the remaining families, linkage test

100 Inquiring whether KCNV2 is the cause of disease in the remaining patients with cone-dom

101 human pathogen continues to be a significant cause of disease in this broad spectrum of patients beca

102 Mutations in ABCA4 were the most common cause of disease in this cohort (173 families), whereas

103 icularly high levels in the striatum, as the cause of disease in this family.

104 er gene family (gene symbol: SLC52A2) as the cause of disease in this family.

105 actin-filament crosslinking protein, as the cause of disease in three families with an autosomal dom

106 ed primarily by Aedes mosquitos and is major cause of disease in tropical and subtropical regions.

107 Although they are recognized as a leading cause of disease in young children, the cellular factors

108 acteria - vibrios - are a globally important cause of diseases in humans and aquatic animals.

109 individuals can be summed to understand the causes of disease in populations, academic epidemiology

110 tations; however, the translation of genetic causes of disease into pathobiological understanding rem

111 ynaptic function in disease once the primary cause of disease is abrogated.

112 The likely cause of disease is the missplicing of the PRPH2 message

113 candidate gene approach to identifying novel causes of disease is concept-limiting and in the new era

114 lop new approaches that directly address the cause of disease, leading to disease remission and ultim

115 cal information-demographic characteristics, cause of disease, liver-related blood tests, tumour char

116 le of multiple component, often interacting, causes of disease may be impossible with research tools

117 ility that both presynaptic and postsynaptic causes of disease might also exist in related disorders,

118 Influenza remains a significant cause of disease mortality.

119 Although they are a common cause of disease, no systematic cost-of-illness studies

120 Staphylococcus aureus is a common cause of disease, particularly in colonized persons.

121 stion might provide crucial insight into the cause of disease pathology at its earliest stages of dev

122 c response (CCR), implicating mutations as a cause of disease persistence.

123 pse suggesting that progressive LOH may be a cause of disease progression and/or drug resistance.

124 ditional chromosomal abnormalities are major causes of disease progression in chronic lymphocytic leu

125 es to revolutionize medicine by treating the causes of disease rather than the symptoms.

126 (P-gp) expression has been reported to be a cause of disease recurrence in osteosarcoma.

127 Although cancer remains the most common cause of disease-related death in adolescents and young

128 orders directed at correcting the underlying cause of disease represents the most significant recent

129 Identifying the underlying causes of disease requires accurate interpretation of ge

130 tissue remodeling and scarring, the ultimate cause of disease sequelae.

131 pe emm59 GAS, heretofore an exceedingly rare cause of disease, spread west to east across Canada over

132 actions can alter physiology and be the root cause of disease states.

133 with enteric pathogens are among the leading causes of disease, suffering, and death worldwide.

134 tis, the same genotype was implicated as the cause of disease, suggesting persistence of the organism

135 expression has been perceived as a potential cause of disease, there is mounting evidence that some E

136 Dystrophin deficiency is the underlying cause of disease; therefore, mutation-specific therapies

137 a second mutation, should not be taken as a cause of disease unless corroborated by family data and

138 ntific curiosity, but also to understand the causes of disease well enough to predict risks, make ear

139 tinues to evolve as it seeks to pinpoint new causes of disease with the hope of advancing personalize

140 Entamoeba histolytica is a significant cause of disease worldwide.

141 ency is a common and potentially devastating cause of disease worldwide.

142 Human noroviruses are a major global cause of disease, yet we know very little about their pa